ArticleProteins2026
Molecular Dynamics Analysis of Inhibitor Binding Interactions in the Vibrio cholerae Respiratory Complex NQR.
Article in Proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Molecular Dynamics Analysis of Inhibitor Binding Interactions in the Vibrio cholerae Respiratory Complex NQR.Proteins · 2026Article
- NQR as a target for new antibiotics.Frontiers in microbiology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The sodium-pumping ubiquinone oxidoreductase sodium pumping quinone reductase (NQR) is an important enzyme in the respiratory chain of multiple pathogenic gram-negative bacteria. NQR has been proposed as a viable antibiotic target due to its importance in supporting energy-consuming reactions and its absence in human cells. In this study, molecular dynamics simulations were conducted to characterize the interactions between the ubiquinone binding pocket of Vibrio cholerae NQR with its substrate analogue ubiquinone-4 and three potent inhibitors: HQNO, aurachin-D42, and korormicin-A. Through interaction fingerprinting, distance calculations, and clustering analysis, important binding motifs for each of these ligands were identified. Subunit B residues K54, F137, E144, V145, V155, E157, G158, F159, and F160 were frequently identified as establishing either hydrogen bonding interactions or hydrophobic interactions with these three ligands. The findings of this in silico study are interpreted in view of mutagenesis analyses previously published in the literature. The elucidation of important binding interactions associated with the inhibitors is critical as it informs structure-activity relationships, which are essential for the development of novel antibiotics targeting NQR.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.